Michael J. LaBarre - Feb 15, 2023 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF TECHNICAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Feb 15, 2023
Transactions value $
-$541,504
Form type
4
Date filed
2/17/2023, 05:29 AM
Previous filing
Feb 14, 2023
Next filing
Feb 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Sale -$484K -10K -6.52% $48.39 143K Feb 15, 2023 Direct F1
transaction HALO Common Stock Options Exercise $0 +3.39K +2.36% $0.00 147K Feb 15, 2023 Direct
transaction HALO Common Stock Tax liability -$57.6K -1.17K -0.8% $49.20 146K Feb 15, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -3.39K -33.33% $0.00 6.77K Feb 15, 2023 Common Stock 3.39K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The reported disposition of 1,170 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F3 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.